Suitability and user acceptance of the eResearch system "Prospective Monitoring and Management App (PIA)"-The example of an epidemiological study on infectious diseases.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
01
2022
accepted:
19
12
2022
entrez:
3
1
2023
pubmed:
4
1
2023
medline:
6
1
2023
Statut:
epublish
Résumé
The eResearch system "Prospective Monitoring and Management App (PIA)" allows researchers to implement questionnaires on any topic and to manage biosamples. Currently, we use PIA in the longitudinal study ZIFCO (Integrated DZIF Infection Cohort within the German National Cohort) in Hannover (Germany) to investigate e.g. associations of risk factors and infectious diseases. Our aim was to assess user acceptance and compliance to determine suitability of PIA for epidemiological research on transient infectious diseases. ZIFCO participants used PIA to answer weekly questionnaires on health status and report spontaneous onset of symptoms. In case of symptoms of a respiratory infection, the app requested participants to self-sample a nasal swab for viral analysis. To assess user acceptance, we implemented the System Usability Scale (SUS) and fitted a linear regression model on the resulting score. For investigation of compliance with submitting the weekly health questionnaires, we used a logistic regression model with binomial response. We analyzed data of 313 participants (median age 52.5 years, 52.4% women). An average SUS of 72.0 reveals good acceptance of PIA. Participants with a higher technology readiness score at the beginning of study participation also reported higher user acceptance. Overall compliance with submitting the weekly health questionnaires showed a median of 55.7%. Being female, of younger age and being enrolled for a longer time decreased the odds to respond. However, women over 60 had a higher chance to respond than women under 60, while men under 40 had the highest chance to respond. Compliance with nasal swab self-sampling was 77.2%. Our findings show that PIA is suitable for the use in epidemiologic studies with regular short questionnaires. Still, we will focus on user engagement and gamification for the further development of PIA to help incentivize regular and long-term participation.
Sections du résumé
BACKGROUND
The eResearch system "Prospective Monitoring and Management App (PIA)" allows researchers to implement questionnaires on any topic and to manage biosamples. Currently, we use PIA in the longitudinal study ZIFCO (Integrated DZIF Infection Cohort within the German National Cohort) in Hannover (Germany) to investigate e.g. associations of risk factors and infectious diseases. Our aim was to assess user acceptance and compliance to determine suitability of PIA for epidemiological research on transient infectious diseases.
METHODS
ZIFCO participants used PIA to answer weekly questionnaires on health status and report spontaneous onset of symptoms. In case of symptoms of a respiratory infection, the app requested participants to self-sample a nasal swab for viral analysis. To assess user acceptance, we implemented the System Usability Scale (SUS) and fitted a linear regression model on the resulting score. For investigation of compliance with submitting the weekly health questionnaires, we used a logistic regression model with binomial response.
RESULTS
We analyzed data of 313 participants (median age 52.5 years, 52.4% women). An average SUS of 72.0 reveals good acceptance of PIA. Participants with a higher technology readiness score at the beginning of study participation also reported higher user acceptance. Overall compliance with submitting the weekly health questionnaires showed a median of 55.7%. Being female, of younger age and being enrolled for a longer time decreased the odds to respond. However, women over 60 had a higher chance to respond than women under 60, while men under 40 had the highest chance to respond. Compliance with nasal swab self-sampling was 77.2%.
DISCUSSION
Our findings show that PIA is suitable for the use in epidemiologic studies with regular short questionnaires. Still, we will focus on user engagement and gamification for the further development of PIA to help incentivize regular and long-term participation.
Identifiants
pubmed: 36595548
doi: 10.1371/journal.pone.0279969
pii: PONE-D-22-02047
pmc: PMC9810156
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0279969Informations de copyright
Copyright: © 2023 Ortmann et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Med Syst. 2018 Jan 25;42(3):45
pubmed: 29372420
Eur J Epidemiol. 2003;18(10):929-31
pubmed: 14598921
Eur J Epidemiol. 2006;21(2):103-11
pubmed: 16518678
Int J Public Health. 2015 Dec;60(8):937-43
pubmed: 26370905
Sci Rep. 2017 May 12;7(1):1855
pubmed: 28500287
Eur J Epidemiol. 2014 May;29(5):371-82
pubmed: 24840228
PLoS One. 2012;7(11):e48508
pubmed: 23155387
JMIR Mhealth Uhealth. 2020 Oct 14;8(10):e17377
pubmed: 33052134
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Nov;57(11):1308-14
pubmed: 25293887
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
Euro Surveill. 2014 Jan 30;19(4):
pubmed: 24507468
Epidemiol Infect. 2014 Oct;142(10):2024-35
pubmed: 24480146
Int J Infect Dis. 2011 Nov;15(11):e799-803
pubmed: 21852171
Front Psychol. 2019 Dec 10;10:2791
pubmed: 31920836
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Mar;63(3):254-266
pubmed: 32047976
J Med Syst. 2015 Feb;39(2):1
pubmed: 25600193
Health Informatics J. 2016 Jun;22(2):184-93
pubmed: 24986104
Int J Infect Dis. 2011 Sep;15(9):e589-93
pubmed: 21641847
Telemed J E Health. 2014 Jan;20(1):39-46
pubmed: 24161004
Influenza Other Respir Viruses. 2019 Jul;13(4):319-330
pubmed: 30925029
J Biomed Inform. 2017 Jul;71:31-48
pubmed: 28536062
Int J Infect Dis. 2014 Aug;25:4-10
pubmed: 24813875
Cochrane Database Syst Rev. 2009 Jul 08;(3):MR000008
pubmed: 19588449